Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05730010

Discerning the Impact of ctDNA Detection on Patient Decision Making in Early Stage Breast Cancer: a Conjoint Analysis

Conditions: Triple Negative Breast Cancer

Sex: All

Ages: 18 Years – N/A

Enrollment: 200

Sponsor: Indiana University

Location: United States

Summary

This study will examine how ctDNA and additional prognostic genomic information in patients with early stage breast cancer might influences patient decision- making regarding systemic therapy options.

Eligibility Criteria

Inclusion Criteria:Self- reported history of non-metastatic breast cancerSelf- reported history of receiving chemotherapy for breast cancerSelf- reported history of chemotherapy completed at least 6 months ago but no more than 10 years agoAble to complete an online surveyEnglish speakingExclusion Criteria:N/A

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05730010). StuddyBuddy aggregates publicly available trial information.